Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function
NCT01569815
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Mild and Moderate Renal Impairment
Interventions
DRUG:
LCZ696
Sponsor
Novartis Pharmaceuticals